Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

(2014) Raquel Levin et al.   Frontiers in Pharmacology

 FosB Induction in Striatal Medium Spiny Neuron Subtypes in Response to Chronic Pharmacological, Emotional, and Optogenetic Stimuli

(2013) M. K. Lobo et al.   JOURNAL OF NEUROSCIENCE

NMDA receptor-dependent function and plasticity in inhibitory circuits

(2013) Alexandre W. Moreau et al.   NEUROPHARMACOLOGY

ΔFosB Induction in Prefrontal Cortex by Antipsychotic Drugs is Associated with Negative Behavioral Outcomes

(2013) David M Dietz et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats

(2012) Anand Gururajan et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia

(2012) C S Weickert et al.   MOLECULAR PSYCHIATRY

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

(2012) A. C. Campos et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice

(2012) Leonora E. Long et al.   PLoS One

NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia

(2012) G. Gonzalez-Burgos et al.   SCHIZOPHRENIA BULLETIN

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia

(2012) Thomas L. Schwartz et al.   Frontiers in Pharmacology

Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia

(2011) Anand Gururajan et al.   BEHAVIOURAL BRAIN RESEARCH

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

(2011) Nurith Amitai et al.   NEUROPHARMACOLOGY

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

(2010) Plinio C. Casarotto et al.   BEHAVIOURAL PHARMACOLOGY

Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine

(2010) Cinzia Guidali et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice

(2009) A.C. Issy et al.   BEHAVIOURAL BRAIN RESEARCH

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

(2009) Juan E Belforte et al.   NATURE NEUROSCIENCE

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Neurochemical, behavioral and architectural changes after chronic inactivation of NMDA receptors in mice

(2009) Mary Elhardt et al.   NEUROSCIENCE LETTERS

Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

(2008) Daniela Vigano et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

(2008) Věra Bubeníková-Valešová et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

(2008) John E. Lisman et al.   TRENDS IN NEUROSCIENCES